Wellness

Go-to migraine drug actually does nothing to relieve vertigo symptoms

Predominantly

aleksandr zubkov/getty images

It seems that the drug usually described for migraines does little to relieve this vestibular, which causes dizziness, along with more typical symptoms such as headaches and sensitivity to light. This is despite the medicine, which is called a resatan, sometimes it runs It is recommended for these types of migraines.

Research related to vestibular migraine treatment was largely inconsistent, which show mixed results of a group of medicines, he says Jeffrey Stap In Mayo Clinic in Rochester, Minnesota. Some of the latest medications like Galcanezumab may Reducing the number of times such attacks occurHowever, so far, no random experience has been tested whether the mid -headache drugs reduce the symptoms of vestibule during the episode itself.

To treat this gap, Stap and his colleagues recruited 134 adults with a vestibular migrain Fake At the beginning of the symptoms of vestibule, such as balance problems or a feeling of rotation, within a total of 307 moderate to severe episodes. Then they classified their symptoms on a scale from 0 to 3 at multiple points in time until the loop was solved.

One hour after taking the medicine – when Resatan It reaches the peak of its concentration In the bloodstream – it was not more effective than the imaginary medicine to relieve any symptoms, though It is often credited with the medicine for its quick work. People in both groups were also likely to turn into a reserve medicine after waiting for an hour required.

After 24 hours, it seemed that Rizatriptan provides a slightly better comfort for movement, light and sound, but not for dizziness. Participants also reported marginal higher degrees of physical luxury-such as energy levels and their ability to carry out daily tasks-compared to the imaginary medicine, but with no difference in mental welfare or side acceptance.

Rizatriptan belongs to a class of Drugs Stap says Tribtan, which is generally effective to treat migraines, but may not work for the symptoms of vestibule.

The results indicate that the brain tracks participating in the vestibular migraines – vestibular systems, which are “completely primitive” from an evolutionary perspective – lack the trap allergy, for reasons that have not yet been explored, Peter Jadsby At King’s College London. However, vestibular migraines should not be classified as a separate case from other migraines, he says, instead, that its symptoms represent “small transformations” in migraine disease that require the targeted treatment strategy.

“You need to ask about these symptoms,” Guadsby says. “And if you deal with a person with vestibular migraines – for example, with Triban – you should be ready for lack of work, and understanding that this does not mean that the patient is difficult or unreasonable.”

Topics:

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button